Generate Biomedicines, Inc. (GENB)
NASDAQ: GENB · Real-Time Price · USD
12.47
+0.02 (0.16%)
At close: Apr 28, 2026, 4:00 PM EDT
12.71
+0.24 (1.92%)
After-hours: Apr 28, 2026, 6:54 PM EDT
Generate Biomedicines Market Cap
Generate Biomedicines has a market cap or net worth of $1.59 billion as of April 28, 2026.
Market Cap
1.59B
Enterprise Value
1.43B
1-Year Change
n/a
Ranking
Category
Stock Price
$12.47
Market Cap Chart
Since the IPO on February 27, 2026, Generate Biomedicines's market cap has decreased from $2.04B to $1.59B, a decrease of -22.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.59B | -22.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 1.71B |
| Rapport Therapeutics | 1.69B |
| Nanobiotix | 1.61B |
| Oculis Holding AG | 1.60B |
| Nuvation Bio | 1.59B |
| AtaiBeckley | 1.58B |
| Monte Rosa Therapeutics | 1.54B |
| Intellia Therapeutics | 1.54B |